Press Releases Archives - Page 3 of 9 - Brainstrust, brain tumour charity

Posted 9th March 2021

How creativity helps Anita with her brain tumour

We spoke to Anita about how she has used creativity as a tool to help her move forward following her brain surgery. In 2018, Anita had two operations to remove two meningioma brain [...]

By Will @ brainstrust

Posted 2nd March 2021

Nine NHS hospital brain tumour centres awarded centre of excellence status

With 12,000 people diagnosed with a brain tumour every year, and with March being UK Brain Tumour Awareness Month, there has never been a more important time to recognise the work of the teams [...]

By Will @ brainstrust

In Campaign News, Do your own thing, Press Releases

Posted 24th February 2021

“Art is magical to me” – how creativity has helped Lou on her brain tumour journey

How creativity has helped Lou throughout lockdown, and her brain tumour journey Since the start of the Coronavirus pandemic last year, the pace of life as we had previously known it suddenly [...]

By Will @ brainstrust

In Brain News, Patient story, Press Releases

Posted 25th January 2021

“Squeeze enjoyment out of every day” – Chris’ GBM journey

Chris’ GBM journey Chris was born at Nether Edge Hospital in Sheffield on 8th January 1973. He is proud to have been born in Sheffield and lived there until he was 27. Dronfield holds a [...]

By Will @ brainstrust

In Charity News, Press Releases

Posted 14th January 2021

New year, new look – first, we are people.

First, we are people. In late 2019 we embarked on our new strategy that cements our commitment to support people with a brain tumour and their caregivers. Being diagnosed with a brain tumour is [...]

By Will @ brainstrust

In Brain News, Press Releases

Posted 8th January 2021

COVID-19 and brain tumours: Shielding update Jan 2021

Updated shielding advice On Monday 4th January, the government announced details of new national restrictions in England that will come into effect from Tuesday 5th January and will run initially [...]

By Will @ brainstrust

In Brain News, Press Releases, Research News

Posted 21st December 2020

Covid-19 and brain tumours – shielding and Tier 4, December 2020

By Will @ brainstrust

In Press Releases, Research News

Posted 14th December 2020

23-02 UPDATE: The COVID-19 vaccine and brain tumours

COVID-19 Vaccine – what this means for people living with a brain tumour On this page you will find information about what we know at the moment about the vaccination programme for COVID-19 [...]

By Will @ brainstrust

In Charity News, Press Releases

Posted 2nd October 2020

The latest Logbook has landed

The eleventh edition of the Logbook is here! Like the rest of the world we’ve been busy adapting to a ‘new normal’ in the face of the Covid-19 pandemic, and this is going to be the focus of this [...]

By Will @ brainstrust

In Brain News, Patient story, Press Releases

Posted 29th September 2020

Memory mishaps: life after brain surgery

Action for Brain Injury Week this year is focusing on memory loss after acquired brain injury. After Anita had two operations on her brain to remove two tumours, she faced many obstacles as a [...]

1 2 3 4 5 6 7 8 9

page 1 of 9

Introduction

The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

Select the year of diagnosis using the drop down menu.
Select your patient group of interest from the four drop down menus in the following order:
1. Tumour group
2. Age at diagnosis
3. Region of England
4. Gender of patient
To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

Data is not yet available for the selected year from Public Health England.
Data is not available because the data quality is too poor to release this statistic.
Data is not available as the statistic is not appropriate for this group.
Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Incidence

The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.

Malignant

Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites

Mortality

The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.

Non-malignant

Not cancerous. Non-malignant tumours may grow larger but do not spread to other parts of the body.

Survival

The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.

More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

http://www.cancerresearchuk.org/health-professional/cancer-statistics/cancer-stats-explained/statistics-terminology-explained#heading-Seven

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here:

https://www.brainstrust.org.uk/advice-glossary.php

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.